The CJEU’s decision in the Kanavape case will have a tremendous impact on the CBD industry in the European Union (EU). However, the breadth of its impact is not yet fully realised. This report examines what we can already determine from the CJEU’s opinion and some implications that it may have depending on how EU member states and courts interpret the ruling.

Free Sample

Table of contents

  1. Executive summary
  2. Introduction
  3. What we know
  4. What does the Kanavape decision mean for novel foods and the cosmetics catalogue?
  5. To what extent can member states regulate the production and processing of CBD products inside its borders?
  6. What does it mean for broad and full spectrum products?
  7. What are the implications for the sale of hemp flower?
  8. Could the precedent from Kanavape be applied outside of the CBD regime?

Need help?

Contact a sales representative right now and don’t wait

Erik Galavis
+34 654 320 547
Email Erik

Restricted content. Do you want to read more?

Request report

Interested in buying?
Request more information


Visit store

Check out our reports
available for purchase


Get a free sample of this report:

“ Regulatory report: the implications of the Kanavape case on CBD in the EU ”

    Buy report request information:

    “ Regulatory report: the implications of the Kanavape case on CBD in the EU ”

      Sign up to our platform and you will have access to our latest business and regulatory news analysis, which keeps you updated with the latest hot topics in the sector.